MedElevator Войти в исследования
← Поиск публикаций

DOI 10.55563/clinexprheumatol/i8eh4g

Медицинская библиотека · Clinical and experimental rheumatology · 2026

IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.

Pamfil Cristina, Mihon Maia Ioana, Surdu Victor, Bucșa Camelia, Cabău Georgiana, Damian Laura, Felea Ioana, Onea Teodor Nicolae, Rednic Simona, Talarico Rosaria

СтатьяСистематический обзорПеревод в очереди

Аннотация

OBJECTIVES

Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibroinflammatory condition that may affect any organ. Prostatic involvement is uncommon and under-recognised. The presentation often mimics benign prostatic hyperplasia or prostate carcinoma, causing diagnostic uncertainty. This systematic review synthesises evidence on IgG4-related prostatitis, focusing on clinical manifestations, diagnostic approaches, treatment, and outcomes.

METHODS

Following PRISMA 2020 guidelines, PubMed, Scopus, Web of Science, and Ovid were searched from inception to 12 February 2025. Eligible studies included English-language case reports, case series, and observational studies describing prostatic involvement in IgG4-RD. Data on demographics, clinical and laboratory findings, management, and outcomes were extracted and analysed descriptively.

RESULTS

Fifty studies reporting 66 cases were included. Median age was 64 years (range 20-82). Serum IgG4 concentrations were elevated in most (median 832 mg/dL, range 5-4,500), while prostate-specific antigen (PSA) levels varied widely (0.01-180 ng/mL). Multiorgan involvement occurred in 57.8%, isolated disease in 6.2%. Lower urinary tract symptoms were most frequent (39.6%). Glucocorticoids, mainly prednisone, were the main therapy (69.2%), followed by surgery, chiefly transurethral resection of the prostate. Complete and partial responses occurred in 50.9% and 43.4%. Treatment type correlated with outcome (χ²=49.70; p<0.001). Malignancy (18.5%) was associated with higher mortality (p=0.028).

CONCLUSIONS

IgG4-related prostatitis is a rare and likely under-recognised manifestation of IgG4-RD. Its overlap with benign and malignant prostatic disorders delays diagnosis. Serum IgG4 and PSA are unreliable markers of disease and monitoring. Glucocorticoids remain first-line therapy, with surgery in obstructive cases. Multicentre studies are needed to define prevalence, natural history, and optimal management.

Для цитирования: Pamfil Cristina, Mihon Maia Ioana, Surdu Victor, Bucșa Camelia, Cabău Georgiana, Damian Laura, Felea Ioana, Onea Teodor Nicolae, Rednic Simona, Talarico Rosaria. IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.. Clinical and experimental rheumatology. 2026. DOI: 10.55563/clinexprheumatol/i8eh4g.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.